NEULAND LABORATORIES LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited |
Net Sales | 3928.28 | 4177.49 | 3629.94 | 4070.73 |
Total Expenditure | 2715.63 | 2802.61 | 2660.73 | 2872.14 |
PBIDT (Excl OI) | 1212.65 | 1374.88 | 969.21 | 1198.59 |
Other Income | 21.01 | 30.48 | 20.39 | 80.64 |
Operating Profit | 1233.66 | 1405.35 | 989.6 | 1279.23 |
Interest | 37.41 | 44.33 | 22.14 | 42.89 |
Exceptional Items | NA | NA | NA | NA |
PBDT | 1196.25 | 1361.02 | 967.46 | 1236.34 |
Depreciation | 151.44 | 145.08 | 135.86 | 134.7 |
Profit Before Tax | 1044.81 | 1215.94 | 831.6 | 1101.64 |
Tax | 230.91 | 323.46 | 212.81 | 256.2 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 813.9 | 892.48 | 618.79 | 845.43 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 813.9 | 892.48 | 618.79 | 845.43 |
Minority Interest | NA | NA | NA | NA |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 813.9 | 892.48 | 618.79 | 845.44 |
Equity Capital | 129 | 129.01 | 129.01 | 129.01 |
Face Value (IN RS) | 10 | 10 | 10 | 10 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 63.09 | 69.17 | 47.96 | 65.53 |
Calculated EPS (Annualised) | 252.37 | 276.71 | 191.85 | 262.13 |
No of Public Share Holdings | 8621410 | 8214946 | 8206857 | 8192857 |
% of Public Share Holdings | 67.2 | 64.03 | 63.97 | 63.86 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 30.86 | 32.91 | 26.70 | 29.44 |
PBIDTM% | 31.40 | 33.64 | 27.26 | 31.42 |
PBDTM% | 30.45 | 32.57 | 26.65 | 30.37 |
PBTM% | 26.59 | 29.10 | 22.90 | 27.06 |
PATM% | 20.71 | 21.36 | 17.04 | 20.76 |
"; | Notes | Notes | Notes | Notes |